Bioactivity:

MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (N

CAS nr:

119942-70-0

Purity:

98%

Molecular Weight:

375,89

SMILES:

O=C1N(C)[C@]2(CCN1C)CCN3CCC4=C(OC5=CC=CC=C54)[C@]3([H])C2.[H]Cl

Formula:

C20H26ClN3O2

Pathway:

Target: